Skip to main content
Erschienen in: BMC Infectious Diseases 1/2024

Open Access 01.12.2024 | Matters Arising

Letter to the editor regarding - pleural effusion caused by Trichinella spiralis infection: two case reports

verfasst von: Jean Dupouy-Camet, Fabien Vaylet, Fabrizio Bruschi

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2024

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
Editor’s note: The Editors have invited a response from the authors of the published article to which this Matters Arising refers. At the time of publication, the authors had not submitted their response.
Fabien Vaylet: deceased.
JDC and FB are members of the International Commission on Trichinellosis submitted. https://​submission.​springernature.​com/​submission/​1fdcdec8-2518-465a-832e-0f9ce831c5c4/​review.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
We read with interest the paper entitled “Pleural effusion caused by Trichinella spiralis infection: two case reports”, published by Pan and colleagues in a recent issue of your journal [1]. In brief, the authors described two cases of exudative pleurisy with a high level of mononuclear cells and a positive Trichinella serology. As a matter of fact, pleurisy is not a frequent occurrence during trichinellosis. According to Pawlowski [2], pleurisy can be observed during trichinellosis, either associated with migrating focal lung infiltrations (exudate), or because of hypoalbuminemia and/or circulatory complications (transudate). Gould [3] reports that “pleuritis is infrequent, generally dry, occurs mainly during the later weeks of infection, and is of short duration. A serous effusion may be a manifestation of congestive heart failure”. In the present case, the authors stated that due to a positive Trichinella serology and in the absence of other identified causes, these pleural effusions could be of parasite origin. However, the presence of Trichinella antibodies does not necessarily indicate an active infection, as the antibodies can persist in the blood for months or even years after the initial infection has been overcome [4]. Moreover, no clinical signs of acute trichinellosis (fever, myalgia, or facial edema) were reported. Rather, case 1 acquired trichinellosis from eating undercooked pork sausages 1.5 months before the occurrence of pleuritis and then showed gastrointestinal symptoms (diarrhea). These observations are not definitive proof of Trichinella infection. In addition, the patient had no muscular involvement, and it is well known that muscular pain usually lasts for several weeks after an infection with Trichinella. Pleural fluid cytology analysis of the two cases detected the presence of lymphocytes (not eosinophils), suggesting tuberculosis or malignancies, as mentioned by the authors. Nevertheless, case 1 displayed no obvious abnormality by either sonography (urological and cardiac), or positron emission tomography. Other possible causes of pleurisy were not investigated, such as viral infections or sarcoidosis, as well as connective tissue disorders [5, 6].
As mentioned by the authors, “the detection of parasite antibody IgG indicated Trichinella spiralis (+) by ELISA”. No information is provided about the method used (commercial or home-made test?), or the level of sensitivity and specificity. ELISA is a quantitative method for calculating antibody amounts. The sign + suggests only the presence of antibodies, but not the titer that if low might be compatible with an ancient infection. Several authors have reported on persistence of antibodies, explained by the long survival of Trichinella encapsulated larvae in muscles. Harms et al. [7] in a prospective controlled study of patients found that 38% of the 128 originally infected patients still had IgG antibodies to Trichinella ten years after acute infection. Kociecka et al. [8] identified antibodies in patients infected seven years before. In a study re-evaluating subjects 15 years after they were involved in a trichinellosis outbreak, Pinelli et al. [9] showed by different techniques (ELISA, western-blot) that antibodies were present in nearly all patients. Illic et al. [10] reported anti-Trichinella antibodies in 10 out of 12 patients who acquired trichinellosis between 13 and 18 years before. Therefore, the serological results must be evaluated in conjunction with the individual’s medical history, clinical symptoms, and other laboratory tests to establish a definitive diagnosis. Furthermore, it’s important to note that there are other conditions and infections that can cause a positive Trichinella antibody test, such as other parasitic infections, autoimmune disorders, or cross-reactivity with other antigens. These false-positive results can be eliminated by using more specific techniques, such as western-blot [11].
In the Discussion there are also probable typing or translation mistakes. When describing circulating antigens, the authors stated that these antigens were “produced by live insects”. And further, “after being treated with insect repellent (albendazole or mebendazole), pleural effusion was absorbed, so it was diagnosed as trichinosis”. Trichinella is not an insect, and albendazole and mebendazole are anthelminthic drugs and not insect repellents. The authors should also use throughout the text the word trichinellosis, instead of trichinosis, to designate the disease caused by Trichinella.
To resume, it’s difficult to confirm a link between pleurisy and Trichinella, since the search for alternative causes was not exhaustive combined with a lack of suggestive standard clinical and biological data consistent with active and/or recent trichinellosis. The favorable evolution could have been spontaneous if the pleural effusion had been caused by viruses. Albendazole and mebendazole could have enhanced this favorable evolution through their anti-inflammatory effects, as suggested by recent experimental studies in rodents [12, 13].
This letter is dedicated to Fabien Vaylet who passed away after the initial submission of the manuscript. We also thank Gordon Langsley for the final language revision.

Acknowledgements

This letter is dedicated to Fabien Vaylet who passed away after the initial submission of the manuscript. We also thank Gordon Langsley for the final language revision.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
2.
Zurück zum Zitat Pawlowski ZS. Clinical aspects in man. In: Campbell WC, editor. Trichinella and trichinosis. New York and London: Plenum; 1983. pp. 367–401.CrossRef Pawlowski ZS. Clinical aspects in man. In: Campbell WC, editor. Trichinella and trichinosis. New York and London: Plenum; 1983. pp. 367–401.CrossRef
3.
Zurück zum Zitat Gould SE. Clinical manifestations. In: Gould SE, editor. Trichinosis in man and animals. Springfield: Charles Thomas; 1970. pp. 269–306. Gould SE. Clinical manifestations. In: Gould SE, editor. Trichinosis in man and animals. Springfield: Charles Thomas; 1970. pp. 269–306.
4.
Zurück zum Zitat Bruschi F, Dupouy-Camet J, Trichinellosis. In: Bruschi F, editor. Helminth infections and their impact on Global Public Health. 2nd ed. Vienna: Springer; 2022. pp. 351–96.CrossRef Bruschi F, Dupouy-Camet J, Trichinellosis. In: Bruschi F, editor. Helminth infections and their impact on Global Public Health. 2nd ed. Vienna: Springer; 2022. pp. 351–96.CrossRef
6.
Zurück zum Zitat Nestor J, Huggins T, Kummerfeldt C, DiVietro M, Walters K, Sahn S. Viral diseases affecting the pleura. J Clin Virol. 2013;58:367.CrossRefPubMed Nestor J, Huggins T, Kummerfeldt C, DiVietro M, Walters K, Sahn S. Viral diseases affecting the pleura. J Clin Virol. 2013;58:367.CrossRefPubMed
7.
Zurück zum Zitat Harms G, Binz P, Feldmeier H, Zwingenberger K, Schleehauf D, Dewes W, et al. Trichinosis: a prospective controlled study of patients ten years after acute infection. Clin Infect Dis. 1993;17:637.CrossRefPubMed Harms G, Binz P, Feldmeier H, Zwingenberger K, Schleehauf D, Dewes W, et al. Trichinosis: a prospective controlled study of patients ten years after acute infection. Clin Infect Dis. 1993;17:637.CrossRefPubMed
8.
Zurück zum Zitat Kociecka W, Bruschi F, Marini C, Mrozewicz B, Pielok L. Clinical appraisal of patients and detection of serum antibodies by ELISA and CIA tests in late periods of Trichinella sp. invasion. Parasite. 2001;8(2 Suppl):147.CrossRef Kociecka W, Bruschi F, Marini C, Mrozewicz B, Pielok L. Clinical appraisal of patients and detection of serum antibodies by ELISA and CIA tests in late periods of Trichinella sp. invasion. Parasite. 2001;8(2 Suppl):147.CrossRef
9.
Zurück zum Zitat Pinelli E, Mommers M, Kortbeek LM, Castagna B, Piergili-Fioretti D, Bruschi F. Specific IgG4 response directed against the 45-kDa glycoprotein in trichinellosis: a re-evaluation of patients 15 years after infection. Eur J Clin Microbiol Infect Dis. 2007;26:641.CrossRefPubMed Pinelli E, Mommers M, Kortbeek LM, Castagna B, Piergili-Fioretti D, Bruschi F. Specific IgG4 response directed against the 45-kDa glycoprotein in trichinellosis: a re-evaluation of patients 15 years after infection. Eur J Clin Microbiol Infect Dis. 2007;26:641.CrossRefPubMed
10.
Zurück zum Zitat Ilic N, Vasilev S, Gruden-Movsesijan A, Gnjatovic M, Sofronic-Milosavljevic L, Mitic I. Long lasting immunity in trichinellosis - insight from a small study group. J Helminthol. 2022;96:e35.CrossRefPubMed Ilic N, Vasilev S, Gruden-Movsesijan A, Gnjatovic M, Sofronic-Milosavljevic L, Mitic I. Long lasting immunity in trichinellosis - insight from a small study group. J Helminthol. 2022;96:e35.CrossRefPubMed
11.
Zurück zum Zitat Yera H, Andiva S, Perret C, Limonne D, Boireau P, Dupouy-Camet J. Development and evaluation of a Western blot kit for diagnosis of human trichinellosis. Clin Diagn Lab Immunol. 2003;10:793.PubMedPubMedCentral Yera H, Andiva S, Perret C, Limonne D, Boireau P, Dupouy-Camet J. Development and evaluation of a Western blot kit for diagnosis of human trichinellosis. Clin Diagn Lab Immunol. 2003;10:793.PubMedPubMedCentral
12.
Zurück zum Zitat Wildenberg ME, Levin AD, Ceroni A, Guo Z, Koelink PJ, Hakvoort TBM, et al. Benzimidazoles Promote Anti-TNF Mediated Induction of Regulatory Macrophages and enhance therapeutic efficacy in a murine model. J Crohns Colitis. 2017;11:1480.CrossRefPubMedPubMedCentral Wildenberg ME, Levin AD, Ceroni A, Guo Z, Koelink PJ, Hakvoort TBM, et al. Benzimidazoles Promote Anti-TNF Mediated Induction of Regulatory Macrophages and enhance therapeutic efficacy in a murine model. J Crohns Colitis. 2017;11:1480.CrossRefPubMedPubMedCentral
Metadaten
Titel
Letter to the editor regarding - pleural effusion caused by Trichinella spiralis infection: two case reports
verfasst von
Jean Dupouy-Camet
Fabien Vaylet
Fabrizio Bruschi
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2024
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09163-w

Weitere Artikel der Ausgabe 1/2024

BMC Infectious Diseases 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.